spacer
home > epc > Winter 2014
PUBLICATIONS

European Pharmaceutical Contractor

epc
Winter 2014

   
Text
PDF
bullet
introduction

Editor's Letter

Graham Hughes draws on the focus of clinical research careers in this issue – underlining the fact that, in the CRO industry, it is all about the people.

 
view
download pdf
bullet
Business and Finance
Market Performance

Sales Force


Pharma sales departments which lack the innovative approach matched by the rest of the sector run the risk of falling behind, argues Mark Garritt at ByBox. The traditional representative model needs refreshing if companies are to enjoy ample market growth once more.
 
view
download pdf
bullet
Legal & Regulatory
EU Clinical Trials Regulation

New and Approved


Although the new EU Clinical Trials Regulation is set to improve transparency, streamline processes and reduce administrative burden, Shuna Mason, Roland Wiring and Andrew Payne at CMS are concerned that it will not be a smooth transition.


 
view
download pdf
Serialisation Regulation

Stay on Track


An effective serialisation solution will provide overall business benefits, in addition to greater visibility and collaboration across the entire supply chain. Bearing in mind the scale of counterfeit products and strict regulations, this has never been more essential, contends Diane Palmquist at GT Nexus.
 
view
download pdf
bullet
Clinical Trials Supplies
Supply Chain Management

Pooling Resources


Distributors and sponsors often experience difficulty when maintaining clinical supply availability and a flexibile supply chain. For enhanced manufacturing and management, Kurt Lumsden at PAREXEL Informatics advises adopting a pooling strategy and interactive response technology.

 
view
download pdf
bullet
Electronic Solutions
Electronic Trial Master Files

Wearing Thin


Concerns over electronic trial master file adoption should be discarded, maintains Rik van Mol at Veeva Systems. The costs and regulatory barriers involved are far outweighed by the vast advantages to be had from exploiting this technology.
 
view
download pdf
bullet
Clinical Development
Drug Resistant Bacteria

Immediate Action

Dawn Firmin
at MGB Biopharma highlights the threat of drug-resistant bacteria, which are constantly growing in number. Along with recent political support, she insists that a novel class of antibiotics should become an industry priority

 
view
download pdf
bullet
Science & Innovation: Cancer Focus
Gastric and Oesophageal Cancer

On Target

The survival rate for gastric and oesophageal cancers is stubbornly low, in spite of promising pipeline drugs and the relative success of monoclonal antibodies. Dominic Trewartha at GBI Research investigates this unmet need, stressing the lack of targeted therapies.
 
view
download pdf
bullet
DATA MANAGEMENT
Uniform Data

One for All


To create a complete picture of the drug development world, clinical trial management system data should be collated to enable a common data-sharing platform between businesses, say DrugDev’s Claire Sears and Graeme Benson.
 
view
download pdf
bullet
Risk Management
Risk-Based Monitoring

A Little More Action


BioClinica’s Courtney McBean urges pharma to stop stalling and embrace risk-based monitoring. This modern approach can allow for the most effi cient trial management – when implemented with the correct components – so hesitation in its adoption is unfounded, she asserts.
 
view
download pdf
bullet
STAFF RECRUITMENT & TRAINING
CRO Recruitment

Talent Trap


Retaining top talent is the name of the game, says INC Research's Jan Schreur. As outsourcing and worldwide strategic partnerships have increased, so too has career competition, as well as new opportunities - and for these reasons, boths CROs and clinical research professionals must up their efforts.

 
view
download pdf
Recruitment: Asia Focus

East Meets West


In today's Asian recruitment landscape, there is a desire to employ more local people in senior roles - but the talent pool is somewhat shallow. With a clear skills gap in the region, developing and holding best-in-class staff is no mean feat. RSA's Susan MacDonald discusses the issue with Thomas Meininghaus at Siemens Audiology Solutions.
 
view
download pdf
Professional Development

Through the Ranks


Nikki Harrison at Clinical Professionals reflects on her career path and entry into the industry. She examines how difficult it can be to get a foot in the door of clinical research, and recommends the reintroduction of more substantial support and training for new recruits.

 
view
download pdf
Recruitment Providers

Quality Check


A poor employee provider can damage both wider brand image and internal quality. Matthew Beedle at NonStop Recruitment suggests that companies seek greater awareness of how their staffing is carried out, and ensure their supplier is regulatory-compliant and ethically sound.
 
view
download pdf
bullet
Cool Chain, Labs & Logistics
Temperature-Sensitive Shipments

Sun Screen


In order to sufficiently protect products, a more robust defence is required for air freight cargo, explains Malik Zeniti at DuPont. At a time when global warming shows no sign of slowing, failing to have a reliable solution in place for temperature-sensitive shipments can result in huge losses.
 
view
download pdf

Research and Development
Neurodegeneration and Ageing

Links of Life


Paul Gard and Sara Fidalgo at the University of Brighton look at the links between old age, dementia and depression. They assess their aetiologies and the negative effects that cognitive-enhancing drugs can have on the gastrointestinal tract.
 
view
download pdf
Engineered Nanotechnology

Nano Debate: Part 2


Although we are exposed to nanoparticles through natural sources and in everyday products, they have been shown to damage human health and the environment. Shelley Bowers at Asons Solicitors suggests halting use of engineered nanotechnology until further research is carried out.
 
view
download pdf

Interview
Industry Insight: Data Monitoring

Quality and Quantity


Marc Buyse at CluePoints tells EPC that monitoring improvements and significant expenses do not need to go hand-in-hand.
 
view
download pdf
In Conclusion

Going Viral


When it comes to this year's Ebola outbreak, Graham Hughes questions whether we can still rely on pharma's investment to curb the crisis.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August and November

News and Press Releases

Synpromics announces a research collaboration with GE Healthcare to extend the toolbox for production of biologics

Edinburgh, UK, 4th January 2017 – Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collaboration with GE Healthcare to jointly develop customised synthetic promoters optimised for GE Healthcare’s proprietary biopharmaceutical manufacturing platform.
More info >>

White Papers

Planning the Execution of a Viral Clearance Study

Eurofins BioPharma Product Testing

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >>

Industry Events

Global Bioproduction Summit, 5th-6th February 2018

5-6 February 2018, Hilton San Diego Resort & Spa, CA

After 15 years in Europe, the Global Bioproduction Summit moved to its new home of San Diego in 2016. The Bioproduction Summit delves deep into the world of biological production.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement